Upregulation of COX-2 in OSA may increase superoxide production resulting in increased oxidative stress, platelet activation, endothelial dysfunction, and vasoconstriction [92, 98–100]. This evidence concerns the gene PTGS2 and obstructive sleep apnea syndrome.